From: Sarcomatoid carcinoma presenting as cancers of unknown primary: a clinicopathological portrait
Variable | Overall Survival (months) | Univariate Analysis HR / 95% CI / P-value | Multivariate Analysis HR / 95% CI / P-value | ||||
---|---|---|---|---|---|---|---|
ECOG Performance Status | |||||||
0–1 | 22 | 4.50 | 1.9–10.9 | < 0.001 | 8.68 | 3.0–25.0 | < 0.001 |
≥ 2 | 4 | ||||||
Number of metastatic sites | |||||||
1 site | 22 | 2.41 | 1.3–4.6 | 0.009 | |||
> 1 sites | 7 | ||||||
LDH | |||||||
Normal | 21 | 2.53 | 0.9–7.5 | 0.012 | |||
High | 5 | ||||||
Neutrophil-to-lymphocyte ratio | |||||||
Low | 13 | 2.66 | 1.0–7.1 | 0.004 | 3.41 | 1.3–8.8 | 0.011 |
High | 4 |